ExLibris header image
SFX Logo
Title: Pharmacodynamic Studies to Demonstrate Bioequivalence of Oral Inhalation Products
Source:

Aaps Journal [1550-7416] yr:2015


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. García Arieta, A. "A European Perspective on Orally Inhaled Products:In VitroRequirements for a Biowaiver." Journal of aerosol medicine and pulmonary drug delivery 27.6 (2014): 419-429. Link to SFX for this item
2. Harrison, M J. "Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF)." Journal of cystic fibrosis 13.6 (2014): 692-698. Link to SFX for this item
3. Keating, Gillian M. "Tiotropium Bromide Inhalation Powder." Drugs 72.2 (2012): 273-300. Link to SFX for this item
4. Weers, J. "Pulmonary Formulations: What Remains to be Done?" Journal of aerosol medicine and pulmonary drug delivery 23.Suppl (2010): -23. Link to SFX for this item
5. "Pharmacokinetics; New Pharmacokinetics Findings Has Been Reported by A. Garcia-Arieta et al (A European Perspective on Orally Inhaled Products: In Vitro Requirements for a Biowaiver)." Obesity, Fitness & Wellness Week (2015): 1078-. Link to SFX for this item
6. Ong, David S. "Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort study." Critical care 17.5 (2013). Link to Full Text for this item Link to SFX for this item
7. Anderson, H R. "Satellite-based estimates of ambient air pollution and global variations in childhood asthma prevalence.(Children's Health)(Report)." Environmental health perspectives 120.9 (2012): 1333-. Link to Full Text for this item Link to SFX for this item
8. Moen, Marit D. Drugs 70.17 (2010): 2269-2280. Link to SFX for this item
9. Garcia Arieta, A. "Bioequivalence Requirements in the European Union: Critical Discussion." The AAPS journal 14.4 (2012): 738-748. Link to Full Text for this item Link to SFX for this item
10. Karhale, A. "Pulmonary drug delivery system." International journal of pharm tech research 4.1 (2012): 293-305. Link to SFX for this item
11. Zaniolo, O. "Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy." The European journal of health economics 13.1 (2010): 1-80. Link to Full Text for this item Link to SFX for this item
12. Zijlstra, G. "Pharmacoeconomic review of recombinant human DNase in the management of cystic fibrosis." Expert review of pharmacoeconomics & outcomes research 4.1 (2004): 49-59. Link to SFX for this item
13. Standaert, T.. "The choice of compressor effects the aerosol parameters and the delivery of tobramycin from a single model nebulizer." Journal of aerosol medicine 13.2 (2000): 147-153. Link to SFX for this item
14. GROTBERG, JB. "INTERACTION OF EXOGENOUS AND ENDOGENOUS SURFACTANT - SPREADING-RATE EFFECTS." Journal of applied physiology 78.2 (1995): 750-756. Link to SFX for this item
15. Raimondi, A C C. "Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder." Chest 112.1 (1997): 24-8. Link to SFX for this item
16. Dunbar, C. "In vitro and in vivo dose delivery characteristics of large porous particles for inhalation." International Journal of Pharmaceutics 245.1-2 (2002): 179-89. Link to Full Text for this item Link to SFX for this item
17. Chan, H. "Changes in Lung Deposition of Aerosols due to Hygroscopic Growth: A Fast SPECT Study." Journal of aerosol medicine 15.3 (2002): 307-311. Link to SFX for this item
18. Li, Hao-Ying Y. "Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy." Journal of drug targeting 11.7 (2003): 425-432. Link to SFX for this item
19. Restrepo, Ruben D D. "Use of inhaled anticholinergic agents in obstructive airway disease." Respiratory care 52.7 (2007): 833-51. Link to SFX for this item
20. Alvarez, E. "New targets for non-small-cell lung cancer therapy." Expert Review of Anticancer Therapy 7.10 (2007): 1423-37. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced